Linda retired from Bristol-Myers Squibb (BMS) as Vice President and Head of Immuno-Oncology/Oncology...
Mark Moody, PhD has more than twenty years of industry experience in multiple areas of drug development,...
Director
Linda retired from Bristol-Myers Squibb (BMS) as Vice President and Head of Immuno-Oncology/Oncology...
Head CMC, Director
Mark Moody, PhD has more than twenty years of industry experience in multiple areas of drug development,...